180 related articles for article (PubMed ID: 12667100)
1. Targeting c-Myb expression in human disease.
Ramsay RG; Barton AL; Gonda TJ
Expert Opin Ther Targets; 2003 Apr; 7(2):235-48. PubMed ID: 12667100
[TBL] [Abstract][Full Text] [Related]
2. Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.
Sarvaiya PJ; Schwartz JR; Hernandez CP; Rodriguez PC; Vedeckis WV
Am J Hematol; 2012 Oct; 87(10):969-76. PubMed ID: 22764095
[TBL] [Abstract][Full Text] [Related]
3. Technology evaluation: leukemia therapy, University of Pennsylvania.
Orr RM
Curr Opin Mol Ther; 1999 Jun; 1(3):399-403. PubMed ID: 11713805
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma.
Tichý M; Knopfová L; Jarkovský J; Pekarčíková L; Veverková L; Vlček P; Katolická J; Čapov I; Hermanová M; Šmarda J; Beneš P
Tumour Biol; 2016 Aug; 37(8):10723-9. PubMed ID: 26873484
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and MYB in breast cancer: potential for new therapies.
Gonda TJ; Leo P; Ramsay RG
Expert Opin Biol Ther; 2008 Jun; 8(6):713-7. PubMed ID: 18476782
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells.
Abaza MS; Al-Attiyah RJ; Al-Saffar AM; Al-Sawan SM; Moussa NM
Tumour Biol; 2003; 24(5):241-57. PubMed ID: 15001837
[TBL] [Abstract][Full Text] [Related]
7. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
11. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
13. Myb is required for self-renewal in a model system of early hematopoiesis.
White JR; Weston K
Oncogene; 2000 Feb; 19(9):1196-205. PubMed ID: 10713708
[TBL] [Abstract][Full Text] [Related]
14. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
Weinberg JB; Mason SN
Cancer Res; 1991 Feb; 51(4):1202-9. PubMed ID: 1997162
[TBL] [Abstract][Full Text] [Related]
15. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer.
Sala A
Eur J Cancer; 2005 Nov; 41(16):2479-84. PubMed ID: 16198555
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.
Bujnicki T; Wilczek C; Schomburg C; Feldmann F; Schlenke P; Müller-Tidow C; Schmidt TJ; Klempnauer KH
Leukemia; 2012 Apr; 26(4):615-22. PubMed ID: 21986841
[TBL] [Abstract][Full Text] [Related]
17. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb.
Emambokus N; Vegiopoulos A; Harman B; Jenkinson E; Anderson G; Frampton J
EMBO J; 2003 Sep; 22(17):4478-88. PubMed ID: 12941699
[TBL] [Abstract][Full Text] [Related]
18. c-erbB2 and c-myb induce mouse oocyte maturation involving activation of maturation promoting factor.
Zheng LP; Huang J; Zhang DL; Xu LQ; Li F; Wu L; Liu ZY; Zheng YH
DNA Cell Biol; 2012 Feb; 31(2):164-70. PubMed ID: 21793718
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of c-myb in the chicken pre B-cell line DT40.
Appl H; Klempnauer KH
Oncogene; 2002 May; 21(19):3076-81. PubMed ID: 12082539
[TBL] [Abstract][Full Text] [Related]
20. Targeting the transcription factor Myb by small-molecule inhibitors.
Uttarkar S; Frampton J; Klempnauer KH
Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
